ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1046
0,00%
Bitcoin
66.991,40
-0,13%
Brent Oil
83,76
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. USOTC
  6. AstraZeneca Plc (PK) (AZNCF)

  7. AstraZeneca Plc (PK) (AZNCF) Notícias

AZNCF

AstraZeneca (PK) (AZNCF)

AstraZeneca Plc (PK)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:USOTC:AZNCF
DataHoraFonteTítuloCódigoCompanhia
16/05/202407:41Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
06/03/202409:21Edgar (US Regulatory)Form CERT - Certification by an exchange approving securities for listingUSOTC:AZNCFAstraZeneca Plc (PK)
05/03/202418:40Edgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]USOTC:AZNCFAstraZeneca Plc (PK)
21/02/202410:32Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]USOTC:AZNCFAstraZeneca Plc (PK)
21/02/202410:13Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:AZNCFAstraZeneca Plc (PK)
20/02/202419:19Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansUSOTC:AZNCFAstraZeneca Plc (PK)
20/02/202418:34Edgar (US Regulatory)Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).USOTC:AZNCFAstraZeneca Plc (PK)
12/02/202412:13Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:AZNCFAstraZeneca Plc (PK)
12/12/202319:15Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyUSOTC:AZNCFAstraZeneca Plc (PK)
09/11/202319:07Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipUSOTC:AZNCFAstraZeneca Plc (PK)
01/11/202316:15AllPennyStocks.comBiotech Shares Soar After AstraZeneca Stake & Research CollaborationUSOTC:AZNCFAstraZeneca Plc (PK)
16/08/202317:09Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesUSOTC:AZNCFAstraZeneca Plc (PK)
28/06/202318:28Edgar (US Regulatory)Annual Report of Employee Stock Plans (11-k)USOTC:AZNCFAstraZeneca Plc (PK)
02/06/202313:13Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:AZNCFAstraZeneca Plc (PK)
13/03/202317:38Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)USOTC:AZNCFAstraZeneca Plc (PK)
02/03/202318:55Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)USOTC:AZNCFAstraZeneca Plc (PK)
01/03/202308:27Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)USOTC:AZNCFAstraZeneca Plc (PK)
24/01/202315:59Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:AZNCFAstraZeneca Plc (PK)
08/07/202217:58Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:AZNCFAstraZeneca Plc (PK)
10/06/202217:11Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)USOTC:AZNCFAstraZeneca Plc (PK)
22/02/202219:43Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:AZNCFAstraZeneca Plc (PK)
22/02/202219:19Edgar (US Regulatory)Notice of Iran-related Disclosure Filed Pursuant to Section 13(r)(3) of the Exchange Act (irannotice)USOTC:AZNCFAstraZeneca Plc (PK)
04/02/202211:08Edgar (US Regulatory)Schedule 13gUSOTC:AZNCFAstraZeneca Plc (PK)
30/07/202108:40Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)USOTC:AZNCFAstraZeneca Plc (PK)
13/04/202107:06Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:AZNCFAstraZeneca Plc (PK)
13/04/202107:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:AZNCFAstraZeneca Plc (PK)
09/04/202118:05Edgar (US Regulatory)Amended Securities Registration (foreign Private Issuer) (f-4/a)USOTC:AZNCFAstraZeneca Plc (PK)
19/02/202119:03Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-4)USOTC:AZNCFAstraZeneca Plc (PK)
13/11/202018:08Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...USOTC:AZNCFAstraZeneca Plc (PK)
01/10/202012:06Edgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:AZNCFAstraZeneca Plc (PK)
 Apresentando as notícias mais relevantes sobre:USOTC:AZNCF

Seu Histórico Recente

NASDAQ
FAQJX
Franklin Conservative Al...
GATE
D2TUSDT
Dash 2 Trade
USOTC
ENCTD
Encanto Potash (CE)
COIN
TREXUSD
BIT
F17405
Vontobel Financial Produ...
BIT
UB48L7
Unicredit Bank
DGFX
BSHIBDOGEUSDT
ShibaDoge
COIN
BUNUSD
NASDAQ
GNTAD
NASDAQ
TLGYU
TLGY Acquisition
BIT
UB87PD
Unicredit Bank
ASX
BENJOZ
LSE
CMO
Cmo
EU
FRHC
CAC Health Care
POLO
ADABEARUSDT
3X Short Cardano Token
NASDAQ
TRKN
Trikon
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados